- Filed
- May 6, 2025 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · Apr 30, 2025 | 202.78M sh |
| Stock Repurchased | Q1 2025 · Mar 31, 2025 | $0 |
| Stock Repurchased | Q1 2025 · Mar 31, 2024 | $9.83M |
| Short Term Debt | Q1 2025 · Mar 31, 2025 | $11M |
| Short Term Debt | Q1 2025 · Dec 31, 2024 | $11M |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $319.61M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $387.88M |
| Cash And Equivalents | Q1 2025 · Mar 31, 2024 | $467.01M |
| Stockholders Equity | Q1 2025 · Mar 31, 2025 | $3.17B |
| Stockholders Equity | Q1 2025 · Dec 31, 2024 | $3.11B |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $259.6M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $218.88M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $1.64B |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $1.24B |
| Current Assets | Q1 2025 · Mar 31, 2025 | $1.02B |
| Current Assets | Q1 2025 · Dec 31, 2024 | $1.03B |
| Total Assets | Q1 2025 · Mar 31, 2025 | $5.64B |
| Total Assets | Q1 2025 · Dec 31, 2024 | $5.19B |
| Total Assets | Q1 2025 · Mar 31, 2024 | $5.25B |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 202.36M sh |
| Capex | Q1 2025 · Mar 31, 2024 | $34.04M |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | $24.63M |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | −$1.42 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | −$1.42 |
| Sga Expense | Q1 2025 · Mar 31, 2024 | $12.86M |
| Net Income | Q1 2025 · Mar 31, 2024 | −$287.08M |
| Operating Income | Q1 2025 · Mar 31, 2024 | −$376.42M |